Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Gypsy-Rose Blanchard exclusively told PEOPLE that she is not using weight-loss drugs to lose weight since giving birth to her ...
Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...